发明名称 METHOD FOR THERAPY PREDICTION IN TUMORS HAVING IRREGULARITIES IN THE EXPRESSION OF AT LEAST ONE VEGF LIGAND AND/OR AT LEAST ONE ERBB-RECEPTOR
摘要 The present invention is related to a method for predicting a clinical response of a patient suffering from or at risk of developing a neoplastic disease towards a given mode of treatment, said method comprising the steps of: a) obtaining a biological sample from said patient; b) determining, on a non protein basis, the expression level of at least one gene encoding for a ligand from the Vascular endothelial growth factor (VEGF) family and of and of at least one gene encoding for a receptor from the ErbB-family, or a gene co-expressed therewith, in said sample, c) comparing the pattern of expression levels determined in (b) with one or several reference pattern (s) of expression levels; and d) predicting therapeutic success for said given mode of treatment in said patient or implementing therapeutic regimen targeting the signalling pathway of said ligand and/or receptor is related to in said patient from the outcome of the comparison in step (c).
申请公布号 US2012015827(A1) 申请公布日期 2012.01.19
申请号 US20080745620 申请日期 2008.11.10
申请人 WIRTZ RALPH 发明人 WIRTZ RALPH
分类号 C40B30/00;C07H21/00;C07H21/02;C07H21/04;C12Q1/68;G01N33/50;G01N33/53 主分类号 C40B30/00
代理机构 代理人
主权项
地址